8-K Raphael Pharmaceutical Inc. 2026-09-01: filed_by
| Value | {"cik": "0001415397", "company": "Raphael Pharmaceutical Inc.", "accession": "0001213900-26-096113", "entity_ref": "746b50d3-3ee9-48d5-9447-5d0434cf78cc", "period_of_report": "2026-07-30"} |
|---|---|
| Period | (as of 2026-09-01) |
| Status | current |
| Entity | 8-K Raphael Pharmaceutical Inc. 2026-09-01 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1415397/000121390026096113/0001213900-26-096113-in
Retrieved: 2026-09-01T19:04:04.937794+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/c7ded224-a93c-4585-987a-13cb160fa463
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1415397/000121390026096113/0001213900-26-096113-in
Retrieved: 2026-09-01T19:04:04.937794+02:00
Raw response sha256:
5f40dc072157e31ba6979772e289dc48…Cite as: FACTANKER, https://factanker.com/fact/c7ded224-a93c-4585-987a-13cb160fa463
History
- no predecessors — first report